These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

352 related items for PubMed ID: 15176165

  • 1. Follicular mycosis fungoides: successful treatment with oral bexarotene.
    Shistik G, Scalf LA, Fenske N, Glass LF.
    J Drugs Dermatol; 2004; 3(3):301-4. PubMed ID: 15176165
    [Abstract] [Full Text] [Related]

  • 2. Treatment of mycosis fungoides with oral bexarotene combined with PUVA.
    Stern DK, Lebwohl M.
    J Drugs Dermatol; 2002 Sep; 1(2):134-6. PubMed ID: 12847736
    [Abstract] [Full Text] [Related]

  • 3. Folliculotropic mycosis fungoides responding to bexarotene gel.
    Walling HW, Swick BL, Gerami P, Scupham RK.
    J Drugs Dermatol; 2008 Feb; 7(2):169-71. PubMed ID: 18335654
    [Abstract] [Full Text] [Related]

  • 4. Successful treatment of a folliculotropic mycosis fungoides with bexarotene and PUVA.
    Krönke A, Schlaak M, Arin M, Mauch C, Kurschat P.
    Eur J Dermatol; 2012 Feb; 22(2):259-60. PubMed ID: 22240623
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Juvenile mycosis fungoides treated with bexarotene and PUVA.
    Rodríguez-Vázquez M, García-Arpa M, González-García J.
    Int J Dermatol; 2007 Jan; 46(1):99-102. PubMed ID: 17214731
    [Abstract] [Full Text] [Related]

  • 7. Follicular mycosis fungoides: variability of a rare entity.
    Roeschm A, Schleyer V, Landthaler M, Vogt T.
    Skinmed; 2005 Jan; 4(1):12-7. PubMed ID: 15654159
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. [Mycosis fungoid treated with oral bexarotene: study of 13 cases].
    Roche Gamón E, Pérez Ferriols A, Vilata Corell JJ, Alegre de Miquel V.
    Med Clin (Barc); 2007 Nov 10; 129(17):677. PubMed ID: 18005638
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Low-dose oral bexarotene in combination with low-dose interferon alfa in the treatment of cutaneous T-cell lymphoma: clinical synergism and possible immunologic mechanisms.
    McGinnis KS, Junkins-Hopkins JM, Crawford G, Shapiro M, Rook AH, Vittorio CC.
    J Am Acad Dermatol; 2004 Mar 10; 50(3):375-9. PubMed ID: 14988678
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of bexarotene combined with psoralen-ultraviolet A (PUVA) compared with PUVA treatment alone in stage IB-IIA mycosis fungoides: final results from the EORTC Cutaneous Lymphoma Task Force phase III randomized clinical trial (NCT00056056).
    Whittaker S, Ortiz P, Dummer R, Ranki A, Hasan B, Meulemans B, Gellrich S, Knobler R, Stadler R, Karrasch M.
    Br J Dermatol; 2012 Sep 10; 167(3):678-87. PubMed ID: 22924950
    [Abstract] [Full Text] [Related]

  • 13. Sustained remission of treatment-resistant cutaneous T-cell lymphoma with oral bexarotene.
    Mehlmauer MA.
    Cutis; 2004 Jun 10; 73(6):417-20. PubMed ID: 15224787
    [Abstract] [Full Text] [Related]

  • 14. Extracorporeal photopheresis in combination with bexarotene in the treatment of mycosis fungoides and Sézary syndrome.
    Tsirigotis P, Pappa V, Papageorgiou S, Kapsimali V, Giannopoulou V, Kaitsa I, Girkas K, Papageorgiou E, Stavrianeas N, Economopoulos T, Dervenoulas J.
    Br J Dermatol; 2007 Jun 10; 156(6):1379-81. PubMed ID: 17459033
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Treatment of mycosis fungoides with bexarotene and psoralen plus ultraviolet A.
    Coors EA, Von den Driesch P.
    Br J Dermatol; 2005 Jun 10; 152(6):1379-81. PubMed ID: 15949024
    [No Abstract] [Full Text] [Related]

  • 17. Bexarotene treatment of late-stage mycosis fungoides and Sézary syndrome: development of extracutaneous lymphoma in 6 patients.
    Bouwhuis SA, Davis MD, el-Azhary RA, McEvoy MT, Gibson LE, Knudsen JM, Kist JM, Pittelkow MR.
    J Am Acad Dermatol; 2005 Jun 10; 52(6):991-6. PubMed ID: 15928617
    [Abstract] [Full Text] [Related]

  • 18. Plaque stage mycosis fungoides treated with bexarotene at low dosage and UVB-NB.
    D'Acunto C, Gurioli C, Neri I.
    J Dermatolog Treat; 2010 Jan 10; 21(1):45-8. PubMed ID: 19603308
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Case experience of 308-nm excimer laser therapy compatibility with PUVA and oral bexarotene for the treatment of cutaneous lesions in mycosis fungoides.
    Huang J, Cowper S, Moss J, Girardi M.
    J Drugs Dermatol; 2013 Apr 10; 12(4):487-9. PubMed ID: 23652902
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.